CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis

Journal of Investigative Dermatology

Volumn 132, Issue 2, 2012, Pages 299-303

  Weischer, Maren ^a,b   Heerfordt, Ida M ^a   Bojesen, Stig E ^a,b,c   Eigentler, Thomas ^d   Garbe, Claus ^d   Röcken, Martin ^d   Hölmich, Lisbet Rosenkrantz ^a   Schmidt, Henrik ^e   Klyver, Helle ^f   Bastholt, Lars ^g   Nordestgaard, Børge G ^a,b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f Rigshospitalet   (Denmark)

^g ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; MELANOCORTIN 1 RECEPTOR; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ARTICLE; BODY DISTRIBUTION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; FEMALE; GERMANY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SUN EXPOSURE; GENETICS; HETEROZYGOTE; META ANALYSIS; MIDDLE AGED; RISK FACTOR; SKIN TUMOR;

ADULT; AGED; CASE-CONTROL STUDIES; DENMARK; FEMALE; GERMANY; HETEROZYGOTE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, MELANOCORTIN, TYPE 1; RISK FACTORS; SKIN NEOPLASMS;

EID: 84855959752     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.303     Document Type: Article

References (35)

1. Altman DG, Bland JM (2003) Interaction revisited: the difference between two estimates. BMJ 326:219 (Pubitemid 36143396)
2. Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3:421-9 (Pubitemid 38340288)
3. Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG (2003) Integrin beta3 Leu33Pro homozygosity and risk of cancer. J Natl Cancer Inst 95: 1150-7 (Pubitemid 37045393)
4. Branzei D, Foiani M (2008) Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol 9:297-308 (Pubitemid 351430844)
5. Caini S, Gandini S, Sera F et al. (2009) Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-patholo-gical variant. Eur J Cancer 45:3054-63
6. Curtin JA, Fridlyand J, Kageshita T et al. (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135-47 (Pubitemid 41653105)
7. Cybulski C (2007) Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of origin. Hered Cancer Clin Pract 5:164-79 (Pubitemid 47573519)
8. Cybulski C, Gorski B, Huzarski T et al. (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75:1131-5 (Pubitemid 39532081)
9. Cybulski C, Wokolorczyk D, Huzarski T et al. (2007) A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treat 102:119-22 (Pubitemid 46294966)
10. Debniak T, Gorski B, Cybulski C et al. (2004) Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skin. Melanoma Res 14:121-4 (Pubitemid 38535091)
11. Debniak T, Scott RJ, Gorski B et al. (2008) Common variants of DNA repair genes and malignant melanoma. Eur J Cancer 44:110-4 (Pubitemid 350256939)
12. Dufault MR, Betz B, Wappenschmidt B et al. (2004) Limited relevance of the CHEK2 gene in hereditary breast cancer. Int J Cancer 110:320-5 (Pubitemid 38649881)
13. Einarsdottir K, Humphreys K, Bonnard C et al. (2006) Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk. PLoS Med 3:e168
14. Gerstenblith MR, Shi J, Landi MT (2010) Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis. Pigment Cell Melanoma Res 23:587-606
15. Gudbjartsson DF, Sulem P, Stacey SN et al. (2008) ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40:886-91 (Pubitemid 351913649)
16. Higgins JP, Thompson SG, Deeks JJ et al. (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-60 (Pubitemid 37088507)
17. Huang J, Domchek SM, Brose MS et al. (2004) Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers. J Med Genet 41:e120
18. Landi MT, Bauer J, Pfeiffer RM et al. (2006) MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313:521-2 (Pubitemid 44148456)
19. Newton-Bishop J, Gruis N (2010) Melanoma susceptibility genes. Melanoma Res 20:161-2
20. Newton-Bishop JA, Chang YM, Iles MM et al. (2010) Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom. Cancer Epidemiol Biomarkers Prev 19:2043-54
21. Orlow I, Begg CB, Cotignola J et al. (2007) CDKN2A germline mutations in individuals with cutaneous malignant melanoma. J Invest Dermatol 127:1234-43 (Pubitemid 46625153)
22. Raimondi S, Sera F, Gandini S et al. (2008) MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 122:2753-60 (Pubitemid 351631377)
23. Rashid MU, Jakubowska A, Justenhoven C et al. (2005) German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer. Eur J Cancer 41:2896-903 (Pubitemid 41713129)
24. Rastogi RP, Richa, Kumar A et al. (2010) Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids 2010:592980
25. Scharrer U, Skrzypczak-Zielinska M, Wituszynska W et al. (2010) A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and Thuringia. Cancer Genet Cytogenet 199:48-52
26. Schutte M, Seal S, Barfoot R et al. (2003) Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility. Am J Hum Genet 72:1023-8 (Pubitemid 36403321)
27. Storm HH, Michelsen EV, Clemmensen IH et al. (1997) The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 44:535-9
28. Thompson D, Seal S, Schutte M et al. (2006) A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers. Cancer Epidemiol Biomarkers Prev 15:2542-5 (Pubitemid 46048319)
29. Vahteristo P, Bartkova J, Eerola H et al. (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432-8 (Pubitemid 34800260)
30. Vilenchik MM, Knudson AG (2003) Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer. Proc Natl Acad Sci USA 100:12871-6 (Pubitemid 37339992)
31. Weischer M, Bojesen SE, Ellervik C et al. (2008) CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol 26:542-8 (Pubitemid 351264346)
32. Weischer M, Bojesen SE, Tybjaerg-Hansen A et al. (2007) Increased risk of breast cancer associated with CHEK2*1100delC. J Clin Oncol 25:57-63 (Pubitemid 350003051)
33. Williams PF, Olsen CM, Hayward NK et al. (2011) Melanocortin-1-receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden. Int J Cancer 129:1730-40
34. Wood RD, Mitchell M, Lindahl T (2005) Human DNA repair genes, 2005. Mutat Res 577:275-83 (Pubitemid 41225506)
35. Yajima H, Lee KJ, Zhang S et al. (2009) DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases. J Mol Biol 385:800-10